| Innova Captab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544067 |
NSE Symbol : INNOVACAP |
P/E(TTM) : 58.87 |
|
ISIN Demat : INE0DUT01020 |
Div & Yield% : - |
EPS(TTM) : 13.14 |
|
Book Value(₹) : 126.47 |
Market Cap(₹Cr) : 4,426.63 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 226.83 | 198.10 | 236.46 | 211.73 | 218.63 | 216.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 226.83 | 198.10 | 236.46 | 211.73 | 218.63 | 216.56 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.64 | 6.01 | 1.77 | 2.11 | 0.83 | 2.47 |
| Total Income | 231.48 | 204.11 | 238.23 | 213.84 | 219.46 | 219.03 |
| Total Expenditure | 198.39 | 174.71 | 205.94 | 185.45 | 190.86 | 194.89 |
| PBIDT | 33.09 | 29.40 | 32.29 | 28.39 | 28.61 | 24.15 |
| Interest | 0.09 | 0.12 | 3.81 | 5.20 | 4.45 | 4.98 |
| PBDT | 33.00 | 29.28 | 28.48 | 23.19 | 24.15 | 19.17 |
| Depreciation | 3.06 | 2.93 | 2.97 | 2.81 | 2.69 | 2.84 |
| Tax | 4.72 | 6.89 | 6.61 | 5.75 | 5.94 | 2.48 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.89 | -0.26 | 0.25 | 0.16 | 0.21 | 0.35 |
| Reported Profit After Tax | 22.34 | 19.72 | 18.65 | 14.47 | 15.32 | 13.50 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 22.34 | 19.72 | 18.65 | 14.47 | 15.32 | 13.50 |
| EPS (Unit Curr.) | 3.90 | 3.45 | 3.26 | 3.02 | 3.19 | 2.81 |
| EPS (Adj) (Unit Curr.) | 3.90 | 3.45 | 3.26 | 3.02 | 3.19 | 2.81 |
| Calculated EPS (Unit Curr.) | 3.90 | 3.45 | 3.26 | 3.02 | 3.19 | 2.81 |
| Calculated EPS (Adj) (Unit Curr.) | 3.90 | 3.45 | 3.26 | 3.02 | 3.19 | 2.81 |
| Calculated EPS (Ann.) (Unit Curr.) | 15.61 | 13.78 | 13.04 | 12.06 | 12.76 | 11.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 15.61 | 13.78 | 13.04 | 12.06 | 12.76 | 11.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 57.23 | 57.23 | 57.23 | 48.00 | 48.00 | 48.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.59 | 14.84 | 13.66 | 13.41 | 13.09 | 11.15 |
| PBDTM(%) | 14.55 | 14.78 | 12.04 | 10.95 | 11.05 | 8.85 |
| PATM(%) | 9.85 | 9.95 | 7.89 | 6.83 | 7.01 | 6.23 |